Announcing MPD Foundation's Challenge Grant 2011

Share Article

The Challenge Grant 2011 program is open to new and established investigators working in the area of polycythemia vera, myelofibrosis and essential thrombocythemia. Proposals will be accepted beginning May 1 2010 through September 1 2010.

The MPD Foundation is pleased to announce a Call for Proposals for its 2011 Challenge Grant Program. Worthy projects will advance the understanding of mechanisms of action in the MPD’s and/or contribute to accelerating the discovery and development of new treatments for MPD patients.

The MPD Foundation is a private not-for-profit advocacy organization seeking to fund scientific and medical research in the Myeloproliferative Disorders. The organization focuses specifically on Myelofibrosis, Polycythemia Vera, and Essential Thrombocythemia.

Grants will be awarded in 2 categories:

  •     New Investigator Awards. Two-year grants of $75,000 per year. These grants are aimed at emerging investigators who are considering a career related to research in the myeloproliferative disorders (MPDs) or established investigators in other fields who are interested in bringing their experience, skills and ideas to research in the MPDs.

Projects may be basic or translational research. The proposal should demonstrate an understanding of current science related to the MPDs and should build on that science to help provide a direction for future research. Projects deemed to accelerate the discovery of effective treatments for MPD’s will be considered as having an advantage for New Investigator awards.

  •     Established Investigator Awards. Two-year grants of $150,000 per year. These grants are aimed at researchers with a demonstrated interest and history of achievement in MPD research. Projects can be either basic or translational research, as long as results will contribute to new understanding, new molecular targets, or new treatments for MPDs.

The MPD Foundation believes that active and meaningful collaboration among researchers with diverse expertise will accelerate the discovery of new mechanisms of action and the development of effective treatments for the MPDs. Preference will therefore be given to Established Investigator proposals made by collaborative groups of researchers, at a single or multiple institutions. An interdisciplinary approach will also receive favorable treatment.

Information on the MPD Foundation and the 2011 Challenge Grant Program can be viewed on the Foundation’s website at


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Woehrle
MPD Foundation
Email >
Visit website